Allergen Provocations- HCA Children's Hospital

Allergy in Children Clinical Trial

Official title:

Allergen Provocations at Hans Christian Andersen Children's Hospital

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04331522
• Other study ID #: HCA-AP
• Status: Recruiting
• Start date: October 1, 2018
• Est. completion date: October 2039

Study information

• Verified date: November 2023
• Source: Odense University Hospital
• Contact: Josefine Gradman, phd
• Phone: +4529241375
• Email: josefine.gradman[@]rsyd.dk
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

A prospective study of all allergen provocations performed in children at the Hans Christian Andersen Children's Hospital.

Description:

The purpose of the study is to investigate the impact of co-morbidities, history, and allergen tests on the outcome of allergen provocation tests.

Subjects are children aged 0-18 years old investigated for allergy to foods or antibiotics. Data entered in the database are demographics, co-morbidities, symptoms, SPT, specific IgE and details of the allergen provocations.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 8000
• Est. completion date: October 2039
• Est. primary completion date: October 2038
• Accepts healthy volunteers: No
• Gender: All
• Age group: 0 Years to 18 Years

Eligibility

Inclusion Criteria:

clinical suspicion of allergy to foods or antibiotics informed concent -

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Allergy in Children

Intervention

Diagnostic Test:
• Oral provocation test
Titrated provocation with allergen

Locations

Country	Name	City	State
Denmark	Hans Christian Andersen Children's Hospital	Odense	Odense C

Sponsors (1)

Lead Sponsor	Collaborator
Josefine Gradman

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The association of allergy tests with the result of allergen provocation	The value of specific IgE and SPT to predict the outcome of a allergen provocation	5 years